PH19406A - Novel 6alpha-fluoro-9alpha-chloro-prednisolone 17,21-diesters - Google Patents

Novel 6alpha-fluoro-9alpha-chloro-prednisolone 17,21-diesters

Info

Publication number
PH19406A
PH19406A PH24861A PH24861A PH19406A PH 19406 A PH19406 A PH 19406A PH 24861 A PH24861 A PH 24861A PH 24861 A PH24861 A PH 24861A PH 19406 A PH19406 A PH 19406A
Authority
PH
Philippines
Prior art keywords
9alpha
6alpha
prednisolone
diesters
fluoro
Prior art date
Application number
PH24861A
Other languages
English (en)
Inventor
Peter Macdonald
Original Assignee
Sterosynt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT7927353A external-priority patent/IT1209140B/it
Priority claimed from IT49853/80A external-priority patent/IT1143039B/it
Application filed by Sterosynt Ltd filed Critical Sterosynt Ltd
Publication of PH19406A publication Critical patent/PH19406A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • C07J71/0015—Oxiranes at position 9(11)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PH24861A 1979-11-16 1980-11-14 Novel 6alpha-fluoro-9alpha-chloro-prednisolone 17,21-diesters PH19406A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT7927353A IT1209140B (it) 1979-11-16 1979-11-16 6 alfa-fluoro-prednisolone 17,21-diesteri.
IT49853/80A IT1143039B (it) 1980-10-09 1980-10-09 6-alfa-fluoro-prednisolone 17,21-diesteri

Publications (1)

Publication Number Publication Date
PH19406A true PH19406A (en) 1986-04-10

Family

ID=26328728

Family Applications (2)

Application Number Title Priority Date Filing Date
PH24862A PH17696A (en) 1979-11-16 1980-11-14 Novel 6alpha-fluoro-prednisolone 17,21-diesters and their use
PH24861A PH19406A (en) 1979-11-16 1980-11-14 Novel 6alpha-fluoro-9alpha-chloro-prednisolone 17,21-diesters

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PH24862A PH17696A (en) 1979-11-16 1980-11-14 Novel 6alpha-fluoro-prednisolone 17,21-diesters and their use

Country Status (12)

Country Link
US (2) US4358445A (fi)
EP (3) EP0030615B1 (fi)
AU (3) AU531292B2 (fi)
CA (3) CA1162533A (fi)
DE (3) DE3069074D1 (fi)
DK (3) DK487580A (fi)
ES (3) ES496839A0 (fi)
FI (3) FI803579L (fi)
IE (1) IE50829B1 (fi)
NO (3) NO803450L (fi)
PH (2) PH17696A (fi)
YU (3) YU291380A (fi)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0095894A3 (en) * 1982-05-31 1985-01-02 Ohta Seiyaku Kabushiki Kaisha. 6 alpha-methylprednisolone derivatives
PT78973A (en) * 1984-07-25 1984-08-01 Joao Emerico Villax New preparation process of the 9alpha-fluoro 17,21-acylates or hidroxilades in 17 and 21 chloro-corticosteroid
US5110809A (en) * 1988-03-21 1992-05-05 Bristol-Myers Squibb Company Antifungal gel formulations
US6565885B1 (en) * 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US20060165606A1 (en) * 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
AUPQ899700A0 (en) 2000-07-25 2000-08-17 Borody, Thomas Julius Probiotic recolonisation therapy
CA2473471A1 (en) * 2001-11-29 2003-06-12 Taro Pharmaceuticals U.S.A., Inc. Method for the preparation of 6-alpha-fluoro corticosteroids
CN101759760B (zh) * 2008-11-28 2013-02-13 天津金耀集团有限公司 一种含氟甾体激素的制备
CN101928318A (zh) * 2009-06-24 2010-12-29 天津金耀集团有限公司 一种含氟甾体激素的制备
WO2011151941A1 (ja) 2010-06-04 2011-12-08 国立大学法人東京大学 制御性ｔ細胞の増殖または集積を誘導する作用を有する組成物
US10238694B2 (en) 2011-12-01 2019-03-26 The University Of Tokyo Human-derived bacteria that induce proliferation or accumulation of regulatory T cells
EP3019181A4 (en) 2013-07-09 2016-09-21 Puretech Ventures Llc COMPOSITIONS CONTAINING COMBINATIONS OF BIOACTIVE MICROFLORE DERIVED MOLECULES FOR THE TREATMENT OF DISEASE
CN108727458A (zh) * 2018-05-10 2018-11-02 浙江仙居仙乐药业有限公司 一种17-丙酸酯的合成方法
CN112851734B (zh) * 2019-11-27 2024-02-06 重庆华邦胜凯制药有限公司 一种二丙酸倍他米松的制备方法
CN111944002A (zh) * 2020-07-29 2020-11-17 河南利华制药有限公司 一种倍氯米松二丙酸酯中间体及制备方法

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL241055A (fi) * 1958-07-09
US3499016A (en) * 1958-08-04 1970-03-03 Upjohn Co 6alpha-fluoro-16alpha-methyl derivatives of the pregnane series
GB933859A (fi) * 1958-09-06 1963-08-14 Syntex S.A.
US3007923A (en) * 1959-01-22 1961-11-07 Lab Francais Chimiotherapie Process for the fluorination of 9beta, 11beta-epoxy and 5alpha, 6alpha-epoxy steroids
DE1081153B (de) * 1959-01-23 1960-05-05 Telefunken Gmbh Verfahren zur Bepastung der Emissionsschichttraeger von Flachkathoden mit Emissionsmaterial und Vorrichtung zur Durchfuehrung des Verfahrens
US3714353A (en) * 1959-08-11 1973-01-30 Upjohn Co THERAPEUTIC COMPOSITIONS COMPRISING A 6 alpha ; 9 alpha -DIFLUORO-11 beta ,17 alpha ,21-TRIHYDROXY-16 alpha -METHYL-1,4-PREGNADIENE-3,20-DIONE AND 21-ACYLATES
US3626063A (en) * 1959-08-11 1971-12-07 Upjohn Co Therapeutic compositions comprising 6-fluoro-16-methyl prednisolone, the 21 acylates and salts thereof
CH429716A (de) * 1961-06-24 1967-02-15 Vismara Francesco Spa Verfahren zur Herstellung von 17a-Acyloxy-21-hydroxy-Steroiden
GB1047518A (en) * 1963-06-11 1966-11-02 Glaxo Lab Ltd 17ª‡-monoesters of 11,17,21-trihydroxy steroid compounds
US3463852A (en) * 1966-01-14 1969-08-26 Schering Corp Treating allergies with steroids of the pregnane series
US3422193A (en) * 1966-08-11 1969-01-14 Schering Corp 17-mono esters of corticoids
IT1061787B (it) * 1967-03-01 1983-04-30 Vismara Francesco Spa Miglioramenti relativi alla preparazione di 17 benzoato di betametazone
US3780177A (en) * 1967-06-16 1973-12-18 Warner Lambert Co 17-butyrate,21-ester derivatives of 6alpha,9alpha-difluoroprednisolone,compositions and use
SE339685B (fi) * 1967-06-16 1971-10-18 Warner Lambert Pharmaceutical
US3784692A (en) * 1967-06-16 1974-01-08 Warner Lambert Co 17-propionate,21-ester derivatives of 6alpha,9alpha-difluoroprednisolone,compositions and use
IT1034011B (it) * 1969-06-26 1979-09-10 Vister Vismara Terapeutici S P Processo per la prapratzione di 17 monoesteri di 17 a 21 diossisteroidi per idrolisi die corpispondenti 17 21 ortoesteri ciclici a ph control lato
DE2011559B2 (de) * 1970-03-07 1973-03-08 Schering Ag, 1000 Berlin Und 4619 Bergkamen Verfahren zur herstellung von 9alpha-chlor-11beta-hydroxysteroiden
US3691214A (en) * 1970-06-08 1972-09-12 Warner Lambert Pharmaceutical 17-valerate ester of 6alpha,9alpha-difluoroprednisolone,its compositions and use as an anti-inflammatory agent
US3857941A (en) * 1970-06-22 1974-12-31 Warner Lambert Co Pharmaceutical compositions and use of prednisolone 17-benzoate
DE2144405A1 (de) * 1971-09-04 1973-03-08 Merck Patent Gmbh Verfahren zur herstellung von estern der pregnanreihe
GB1403962A (en) 1972-03-09 1975-08-28 Upjohn Co Anti-inflammatory pregnane derivative
US3980778A (en) * 1973-10-25 1976-09-14 The Upjohn Company Anti-inflammatory steroid
DE2512915A1 (de) * 1974-03-27 1975-10-09 Plurichemie Anstalt 16-methyl-9 alpha-halogen-steroide ester, aether und verfahren zu ihrer herstellung
US4018918A (en) * 1975-05-20 1977-04-19 The Upjohn Company Topical clindamycin preparations
CH611631A5 (en) * 1975-07-23 1979-06-15 Ciba Geigy Ag Process for the preparation of 11,12-unsaturated 9alpha-fluorosteroids
US4036831A (en) * 1975-10-28 1977-07-19 Steroid Development Company Establishment Trimethyl siloxane steroid intermediates
LU75809A1 (fi) * 1976-09-16 1978-05-12
NL187577C (nl) 1978-04-05 1991-11-18 Sibla Srl 3-acetoxy-9beta,11beta-epoxy-pregna-1,3,5-trienen, werkwijze voor de bereiding daarvan en werkwijze voor de bereiding van 6alfa-halogeen-pregna-1,4-dieen-3-onen.
US4261984A (en) * 1978-04-05 1981-04-14 Syntex (U.S.A.) Inc. 17β-thiocarboxylic acid esters of 3-oxo-4-halo-16β-methylandrost-4-enes

Also Published As

Publication number Publication date
DK487480A (da) 1981-05-17
FI803577L (fi) 1981-05-17
DE3071122D1 (en) 1985-10-31
YU41747B (en) 1987-12-31
AU6439080A (en) 1981-05-21
EP0029151A3 (en) 1981-08-26
ES496840A0 (es) 1981-10-16
YU291180A (en) 1983-02-28
DK487680A (da) 1981-05-17
DE3068965D1 (en) 1984-09-20
YU291380A (en) 1983-02-28
NO154268C (no) 1986-08-20
EP0029924A1 (en) 1981-06-10
CA1162532A (en) 1984-02-21
EP0029151A2 (en) 1981-05-27
ES8200120A1 (es) 1981-10-16
FI69474B (fi) 1985-10-31
EP0030615A1 (en) 1981-06-24
AU6438880A (en) 1981-05-21
AU530348B2 (en) 1983-07-14
ES8200121A1 (es) 1981-10-16
CA1162921A (en) 1984-02-28
US4358445A (en) 1982-11-09
FI803579L (fi) 1981-05-17
AU6438980A (en) 1981-05-21
NO803452L (no) 1981-05-18
ES8200122A1 (es) 1981-10-16
AU531292B2 (en) 1983-08-18
DK487580A (da) 1981-05-17
FI803578L (fi) 1981-05-17
ES496841A0 (es) 1981-10-16
NO803451L (no) 1981-05-18
EP0029151B1 (en) 1985-09-25
FI69474C (fi) 1986-02-10
CA1162533A (en) 1984-02-21
EP0029924B1 (en) 1984-08-15
PH17696A (en) 1984-11-08
ES496839A0 (es) 1981-10-16
IE50829B1 (en) 1986-07-23
AU530802B2 (en) 1983-07-28
IE802379L (en) 1981-05-16
US4576936A (en) 1986-03-18
NO154268B (no) 1986-05-12
EP0030615B1 (en) 1984-08-29
NO803450L (no) 1981-05-18
DE3069074D1 (en) 1984-10-04
YU291280A (en) 1983-02-28

Similar Documents

Publication Publication Date Title
GB2064520B (en) A-aryl-1h-1,2,4-triazole-1-ethanols
CS345184A2 (en) Zpusob pripravy n heterocyklyl 4 piperidinaminu
IL60272A0 (en) 7 and 7-8 substituted 4,5 -epoxymorphinan-6-one compounds
ZA802092B (en) Substituted 9,10-anthracene-bishydrazones
PH19406A (en) Novel 6alpha-fluoro-9alpha-chloro-prednisolone 17,21-diesters
GB2058767B (en) 4'-substituted-4,5',8-trialklpsoralens
GB2058766B (en) 5'-aminoalkyl-4,4'-dialkylpsoralens
GB2045765B (en) 24,24-difluoro1,25-dihydroxycholecalciferol
GB2022577B (en) 1,3-diary-2-imino-imidazolidines or hexahydropyrimides
GB2044770B (en) 24,24 - difluoro- 25 - hydroxycholecalciferol
NZ193666A (en) 3-aryl-2-(2,3-dihydrothiazol-2-ylidene)-3-oxopropionitriles
ZA807494B (en) 2,3-indoledione derivatives
NZ194046A (en) Certain 6,7-disubstituted-3-methyl-1,2,3,5-tetrahydro-imidazo (2,1-b)quinazolin-2-ones
GB2125397B (en) 16-oxa-3-methylbicyclo (10.3.1) pentadec-1-ene
CS660880A2 (en) Zpusob vyroby 2 substituovanych 4 substituovanych kyselin 5 thiazolkarboxylovych
ZA804183B (en) 1,2,4-thiadiazolyloxyphenylureas
IL75705A (en) 1,2,5-thiadiazole-1-oxides
GB2075982B (en) 1-3-dihydroxy-27-nor-cholesta-5-en and 5,7-dien-25-one
NZ194583A (en) 5,6-dihydro-11h-pyrimido (4,5-6)(1,5) benzodiazepin-5-ones
IL59681A0 (en) 2,o-dihydro-1,j-bezodioxane derivatives
CS515881A2 (en) Zpusob pripravy oktahydropyrazolo(3,4 g) chinolinu
GB2118169B (en) 1,1,1-trichlorotriacontane
ZA807088B (en) 6a-fluoro-prednisolone 17,21-diesters
GB2042519B (en) 1,1,2-triphenylethane and -ehylene derivatives
GB2055832B (en) 1,3,4-thiadiazol-2-yl-4-hydroxy-1-methyl-2-imidaxolidinones